Understanding the experiences of patients with chronic cancer treatments

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Observational University of Alberta · NCT05645510

This study is trying to understand how people with advanced chronic cancer feel about their targeted treatments by having them share their experiences through interviews and creative expressions like art and music.

Quick facts

Study typeObservational
Enrollment75 (estimated)
Ages18 Years to 90 Years
SexAll
SponsorUniversity of Alberta Academic / other
Locations1 site (Edmonton, Alberta)
Trial IDNCT05645510 on ClinicalTrials.gov

What this trial studies

This observational study focuses on individuals with advanced chronic cancers who are receiving targeted anti-cancer treatments. Participants will engage in interviews to share their experiences with these treatments and reflect on how they impact their daily lives. Over a three-month period, they will create metaphors that express their experiences, using various forms of expression such as visual art, music, or verbal narratives. The goal is to gather insights that can help improve support for patients undergoing these treatments.

Who should consider this trial

Good fit: Ideal candidates are individuals currently receiving chronic targeted anti-cancer agents for conditions like breast cancer, melanoma, or multiple myeloma.

Not a fit: Patients who are not currently undergoing targeted anti-cancer treatments may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the support and resources available to patients undergoing targeted cancer treatments.

How similar studies have performed: While this approach is relatively novel in its focus on personal expression, similar studies have shown success in understanding patient experiences with chronic illnesses.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria: taking chronic targeted anti-cancer agents -

Exclusion Criteria:

\-

Where this trial is running

Edmonton, Alberta

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions CancerTyrosine Kinase MutationBreast CancerMelanomaMultiple MyelomaChronic LeukemiaProstate CancerOvarian Cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.